|
Name |
Sphaeropsidin F
|
Molecular Formula | C20H32O4 | |
IUPAC Name* |
(4R,4aR,4bR,7R,9S,10R,10aS)-7-ethenyl-1,1,4a,7-tetramethyl-2,3,4,5,6,9,10,10a-octahydrophenanthrene-4,4b,9,10-tetrol
|
|
SMILES |
C[C@@]1(CC[C@]2(C(=C1)[C@@H]([C@@H]([C@@H]3[C@@]2([C@@H](CCC3(C)C)O)C)O)O)O)C=C
|
|
InChI |
InChI=1S/C20H32O4/c1-6-18(4)9-10-20(24)12(11-18)14(22)15(23)16-17(2,3)8-7-13(21)19(16,20)5/h6,11,13-16,21-24H,1,7-10H2,2-5H3/t13-,14+,15+,16+,18+,19+,20-/m1/s1
|
|
InChIKey |
MDMNBGISPKQWRE-KNEKMNIZSA-N
|
|
Synonyms |
Sphaeropsidin F; CHEBI:69498; Q27137838; (4R,4aR,4bR,7R,9S,10R,10aS)-7-ethenyl-1,1,4a,7-tetramethyl-2,3,4,5,6,9,10,10a-octahydrophenanthrene-4,4b,9,10-tetrol
|
|
CAS | NA | |
PubChem CID | 10925744 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 336.5 | ALogp: | 1.8 |
HBD: | 4 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 80.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 24 | QED Weighted: | 0.555 |
Caco-2 Permeability: | -4.752 | MDCK Permeability: | 0.00002420 |
Pgp-inhibitor: | 0.3 | Pgp-substrate: | 0.337 |
Human Intestinal Absorption (HIA): | 0.033 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0.747 | Plasma Protein Binding (PPB): | 82.22% |
Volume Distribution (VD): | 1.208 | Fu: | 25.89% |
CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.222 |
CYP2C19-inhibitor: | 0.018 | CYP2C19-substrate: | 0.69 |
CYP2C9-inhibitor: | 0.025 | CYP2C9-substrate: | 0.156 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.073 |
CYP3A4-inhibitor: | 0.419 | CYP3A4-substrate: | 0.195 |
Clearance (CL): | 2.887 | Half-life (T1/2): | 0.327 |
hERG Blockers: | 0.03 | Human Hepatotoxicity (H-HT): | 0.14 |
Drug-inuced Liver Injury (DILI): | 0.032 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.972 | Maximum Recommended Daily Dose: | 0.984 |
Skin Sensitization: | 0.331 | Carcinogencity: | 0.686 |
Eye Corrosion: | 0.02 | Eye Irritation: | 0.289 |
Respiratory Toxicity: | 0.981 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002831 | 0.500 | D0H2MO | 0.317 | ||||
ENC002830 | 0.494 | D0L2LS | 0.267 | ||||
ENC002906 | 0.488 | D0P0HT | 0.262 | ||||
ENC002832 | 0.461 | D0I2SD | 0.248 | ||||
ENC002041 | 0.380 | D04VIS | 0.248 | ||||
ENC001070 | 0.372 | D03BLF | 0.243 | ||||
ENC002834 | 0.370 | D0Q6NZ | 0.240 | ||||
ENC002731 | 0.368 | D0Z1XD | 0.240 | ||||
ENC002087 | 0.363 | D08PIQ | 0.236 | ||||
ENC002099 | 0.356 | D0R7JT | 0.236 |